121 related articles for article (PubMed ID: 20298993)
1. Mortality and morbidity reduction by primary percutaneous coronary intervention is independent of the patient's age.
de Boer SP; Westerhout CM; Simes RJ; Granger CB; Zijlstra F; Boersma E;
JACC Cardiovasc Interv; 2010 Mar; 3(3):324-31. PubMed ID: 20298993
[TBL] [Abstract][Full Text] [Related]
2. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) Registry.
Denktas AE; Athar H; Henry TD; Larson DM; Simons M; Chan RS; Niles NW; Thiele H; Schuler G; Ahn C; Sdringola S; Anderson HV; McKay RG; Smalling RW
JACC Cardiovasc Interv; 2008 Oct; 1(5):504-10. PubMed ID: 19463352
[TBL] [Abstract][Full Text] [Related]
3. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients.
Boersma E;
Eur Heart J; 2006 Apr; 27(7):779-88. PubMed ID: 16513663
[TBL] [Abstract][Full Text] [Related]
4. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
Tarantini G; Razzolini R; Napodano M; Bilato C; Ramondo A; Iliceto S
Eur Heart J; 2010 Mar; 31(6):676-83. PubMed ID: 19946106
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction.
Kent DM; Ruthazer R; Griffith JL; Beshansky JR; Grines CL; Aversano T; Concannon TW; Zalenski RJ; Selker HP
Am J Cardiol; 2007 May; 99(10):1384-8. PubMed ID: 17493465
[TBL] [Abstract][Full Text] [Related]
6. Should primary percutaneous coronary intervention be the routine reperfusion strategy in octogenarians presenting with ST elevation myocardial infarction?
Showkathali R; Boston-Griffiths E; Parker M; Davies JR; Clesham GJ; Sayer JW; Kelly PA; Aggarwal RK
J Cardiovasc Med (Hagerstown); 2014 Jan; 15(1):53-9. PubMed ID: 24500237
[TBL] [Abstract][Full Text] [Related]
7. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).
Nielsen PH; Terkelsen CJ; Nielsen TT; Thuesen L; Krusell LR; Thayssen P; Kelbaek H; Abildgaard U; Villadsen AB; Andersen HR; Maeng M;
Am J Cardiol; 2011 Sep; 108(6):776-81. PubMed ID: 21757183
[TBL] [Abstract][Full Text] [Related]
8. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy).
Madsen MM; Busk M; Søndergaard HM; Bøttcher M; Mortensen LS; Andersen HR; Nielsen TT;
Am J Cardiol; 2005 Dec; 96(11):1469-75. PubMed ID: 16310424
[TBL] [Abstract][Full Text] [Related]
9. High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration.
de Boer SP; Barnes EH; Westerhout CM; Simes RJ; Granger CB; Kastrati A; Widimsky P; de Boer MJ; Zijlstra F; Boersma E
Am Heart J; 2011 Mar; 161(3):500-507.e1. PubMed ID: 21392604
[TBL] [Abstract][Full Text] [Related]
10. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
[TBL] [Abstract][Full Text] [Related]
11. Contemporary clinical outcomes of primary percutaneous coronary intervention in elderly versus younger patients presenting with acute ST-segment elevation myocardial infarction.
Hafiz AM; Jan MF; Mori N; Gupta A; Bajwa T; Allaqaband S
J Interv Cardiol; 2011 Aug; 24(4):357-65. PubMed ID: 21414028
[TBL] [Abstract][Full Text] [Related]
12. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
[TBL] [Abstract][Full Text] [Related]
13. Changes in reperfusion strategy over time for ST segment elevation myocardial infarction in the Greater Paris Area: results from the e-MUST Registry.
Karam N; Lambert Y; Tafflet M; Bataille S; Benamer H; Caussin C; Garot P; Escolano S; Boutot F; Greffet A; Letarnec JY; Capitani GA; Templier F; Lapandry C; Auger A; Dupas F; Dubourdieu S; Juliard JM; Spaulding C; Jouven X;
Int J Cardiol; 2013 Oct; 168(6):5149-55. PubMed ID: 24012174
[TBL] [Abstract][Full Text] [Related]
14. Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.
Sejersten M; Birnbaum Y; Ripa RS; Maynard C; Wagner GS; Clemmensen P;
Heart; 2006 Nov; 92(11):1577-82. PubMed ID: 16740918
[TBL] [Abstract][Full Text] [Related]
15. Impact of 24-hr in-hospital interventional cardiology team on timeliness of reperfusion for ST-segment elevation myocardial infarction.
Allaqaband S; Jan MF; Banday WY; Schlemm A; Ahmed SH; Mori N; Oldridge N; Gupta A; Bajwa T
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1015-23. PubMed ID: 20517963
[TBL] [Abstract][Full Text] [Related]
16. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention.
Brieger D; Collet JP; Silvain J; Landivier A; Barthélémy O; Beygui F; Bellemain-Appaix A; Mercadier A; Choussat R; Vignolles N; Costagliola D; Montalescot G
Catheter Cardiovasc Interv; 2011 Feb; 77(2):182-90. PubMed ID: 20578166
[TBL] [Abstract][Full Text] [Related]
17. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry.
Dziewierz A; Siudak Z; Rakowski T; Chyrchel M; Mielecki W; Janzon M; Birkemeyer R; Tierala I; Wojdyła RM; Dubiel JS; Dudek D
Int J Cardiol; 2010 Aug; 143(2):147-53. PubMed ID: 19559491
[TBL] [Abstract][Full Text] [Related]
18. Trends in acute myocardial infarction treatment between 1998 and 2007 in a Belgian area (Charleroi).
Collart P; Coppieters Y; Levêque A
Eur J Prev Cardiol; 2012 Aug; 19(4):738-45. PubMed ID: 21708835
[TBL] [Abstract][Full Text] [Related]
19. Comparison of impact of mortality risk on the survival benefit of primary percutaneous coronary intervention versus facilitated percutaneous coronary intervention.
Tarantini G; Facchin M; Frigo AC; Welsh R
Am J Cardiol; 2011 Jan; 107(2):220-4. PubMed ID: 21211598
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
